SCHEMBL24914052

SCHEMBL24914052

CN1CCC(Oc2cc3c(c(N[C@@H]4CCOC4)c2)CN(C(=O)OC(C)(C)C)CC3)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.41
▸ NR1H2 P55055 1/20 0.40
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ ESR2 Q92731 1/20 0.38
▸ GPR119 Q8TDV5 4/20 0.38
▸ POLB P06746 1/20 0.37
▸ GPR6 P46095 3/20 0.36
▸ KCNH2 Q12809 2/20 0.36
▸ GCK P35557 2/20 0.35
▸ MTHFD1 P11586 1/20 0.35
▸ MTHFD2 P13995 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ F10 P00742 1/20 0.34
▸ PLG P00747 1/20 0.34
▸ PRSS1 P07477 1/20 0.34
▸ PRSS2 P07478 1/20 0.34
▸ PRSS3 P35030 1/20 0.34
▸ INSR P06213 1/20 0.34
▸ IGF1R P08069 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31014014 0.93 HRH3 (0.40) HRH3NR1H2PRMT5WDR77GPR119
SCHEMBL31014023 0.93 HRH3 (0.40) HRH3NR1H2PRMT5WDR77GPR119
SCHEMBL31013866 0.89 ALDH1A1 (0.43) HRH3NR1H2ESR2ALDH1A1
SCHEMBL29168631 0.88 MTHFD1 (0.39) HRH3PRMT5WDR77POLBGPR6
SCHEMBL31013883 0.86 ESR2 (0.49) NR1H2ESR2ALDH1A1IGF1R
SCHEMBL31013949 0.85 ESR2 (0.38) HRH3NR1H2PRMT5WDR77ESR2
SCHEMBL24913899 0.85 ESR2 (0.39) NR1H2ESR2POLB
SCHEMBL24913918 0.84 GPR119 (0.38) HRH3NR1H2PRMT5WDR77ESR2
SCHEMBL31014038 0.84 GPR119 (0.38) HRH3NR1H2PRMT5WDR77ESR2
SCHEMBL30156745 0.84 GPR119 (0.38) HRH3NR1H2PRMT5WDR77ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240293392-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2024-09-05 — — US disclosed
WO-2023002165-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2023-01-26 — — WO disclosed
WO-2023002165-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2023-01-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240293392-A1 INHIBITOR COMPOUNDS MSH2, PMS2, MSH6 HRH3 1142/4885NR1H2 2027/4885PRMT5 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback